• Bernardi, F., Casonato, A., Marchetti, G., Gemmati, D., Bizzaro, N., Pontara, E. & Girolami, A. (1998) Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28. British Journal of Haematology, 103, 885887.
  • Brown, J.E. & Bosak, J.O. (1986) An ELISA test for the binding of von Willebrand antigen to collagen. Thrombosis Research, 43, 303311.
  • Casonato, A., Fabris, F., Vicariotto, M. & Girolami, A. (1985) The evaluation of factor VIII antigen by means of a simple slide test. American Journal of Clinical Pathology, 29, 309316.
  • Casonato, A., Sartori, M.T., Pontara, E., Zucchetto, S. & Girolami, A. (1992) Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. Blood Coagulation and Fibrinolysis, 3, 149153.
  • Casonato, A., Pontara, E., Bertomoro, A., Zucchetto, S., Zerbinati, P. & Girolami, A. (1997) Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defects depends only on the lack of large multimers. Journal of Laboratory and Clinical Medicine, 129, 251259.
  • Casonato, A., Pontara, E., Zerbinati, P., Zucchetto, A. & Girolami, A. (1998) The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method. American Journal of Clinical Pathology, 109, 347352.
  • Casonato, A., Pontara, E., Bertomoro, A., Sartorello, F. & Girolami, A. (1999) Which assay is the most suitable to investigate von Willebrand factor functional activity? Thrombosis and Haemostasis, 81, 994995.
  • Dent, J.A., Berkowitz, S.D., Ware, J., Kasper, C.K. & Ruggeri, Z.M. (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type II A von Willebrand factor. Proceedings of the National Academy of Sciences of the United States of America, 87, 63066310.
  • Favaloro, E.J., Grispo, L., Exner, T. & Koutts, J. (1991) Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between type I and type II von Willebrand disease. Blood Coagulation and Fibrinolysis, 2, 285291.
  • Favaloro, E.J., Dean, M., Grispo, L., Exner, T. & Koutts, J. (1994) Von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy. American Journal of Haematology, 45, 205211.
  • Favaloro, J.E., Smith, J., Petinos, P., Hertzberg, M. & Koutts, J. (1999) Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thrombosis and Haemostasis, 82, 12761282.
  • Foster, P.A., Fulcher, C.A., Marti, T., Titani, K. & Zimmerman, T.S. (1987) A major binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. Journal of Biological Chemistry, 262, 84438446.
  • Gralnick, H.R., Williams, S.B., McKeown, L.P., Maisonneuve, P.H., Jenneau, C., Sultan, Y. & Rick, M.E. (1985) In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIA von Willebrand disease. Proceedings of the National Academy of Sciences of the United States of America, 82, 59685972.
  • Hoylaerts, M.F., Yamamoto, H., Nuyts, K., Vreys, I., Deckmyn, H. & Vermylen, J. (1997) von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochemistry Journal, 324, 185191.
  • Lankhof, H., Hoeji, M., Schihortst, E., Bracke, M., Wu, Y.-P., Ijsseldijk, M.J.W., Vink, T., De Groot, P.G. & Sixma, J.J. (1996) A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thrombosis and Haemostasis, 75, 950958.
  • Mazzuccato, M., Spessotto, P., Masotti, A., De Apollonia, L., Cozzi, M.R., Yoshioka, A., Perris, R., Colombatti, A. & De Marco, L. (1998) Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow. The Journal of Biological Chemistry, 274, 30333041.
  • McFarlane, D.E., Stibbe, J., Kibby, E.P., Zucher, M.B., Grant, R. & McPerson, J. (1975) A method for assaying von Willebrand factor (ristocetin co-factor). Thrombosis and Diathesis Haemorragica, 34, 306308.
  • Mohri, H., Fujimura, Y., Shima, M., Yoshioka, A., Houghten, R.A., Ruggeri, Z.M. & Zimmerman, T.S. (1988) Structure of the von Willebrand factor domain interacting with glycoprotein Ib. Journal of Biological Chemistry, 263, 1790117904.
  • Rodeghiero, F., Castaman, G. & Dini, E. (1987) Epidemiological investigation of the prevalence of von Willebrand disease. Blood, 69, 454459.
  • Ruggeri, Z.M. & Zimmerman, T.S. (1980) Variant von Willebrand's disease. Characterization of two subtypes by analysis of multimeric composition of FVIII/von Willebrand factor in plasma and platelets. Journal of Clinical Investigation, 65, 13181325.
  • Ruggeri, Z.M. & Zimmerman, T.S. (1987) Von Willebrand factor and von Willebrand disease. Blood, 70, 895904.
  • Sadler, J.E. (1994) A revised classification of von Willebrand disease. For the Subcommittee on Von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, 71, 520525.
  • Sadler, J.E. (1998) Biochemistry and genetics of von Willebrand factor. Annual Review of Biochemistry, 67, 395424.
  • Sadler, J.E. & Gralnick, H.R. (1994) Commentary: a new classification for von Willebrand disease. Blood, 84, 676679.
  • Turitto, V.T., Weiss, H.J. & Zimmerman, T.S. (1985) Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood, 65, 823831.
  • Zimmerman, T.S., Hoyer, L.W., Dickinson, L. & Edgington, T.S. (1975) Determination of the von Willebrand's disease antigen (Factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. Journal of Laboratory and Clinical Medicine, 86, 152159.